Walvax Biotechnology Co., Ltd. (SHE:300142)
10.00
-0.64 (-6.02%)
Nov 20, 2026, 3:04 PM CST
| Market Cap | 15.99B -19.3% |
| Revenue (ttm) | 1.85B -23.0% |
| Net Income | 21.84M -55.7% |
| EPS | 0.01 -55.8% |
| Shares Out | 1.60B |
| PE Ratio | 734.21 |
| Forward PE | n/a |
| Dividend | 0.16 (1.55%) |
| Ex-Dividend Date | Jun 24, 2026 |
| Volume | 37,252,808 |
| Open | 10.97 |
| Previous Close | 10.64 |
| Day's Range | 10.00 - 10.97 |
| 52-Week Range | 10.00 - 16.97 |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |